| ²é¿´: 722 | »Ø¸´: 1 | ||
icyuhand½ð³æ (СÓÐÃûÆø)
³ôƤ
|
[ÇóÖú]
¡¾ÊµÑéÇóÖú¡¿ÑÛµ×£¨²¿£©ÐÂÉúѪ¹ÜÄ£ÐÍ/ÌåÍâ¡¢ÌåÄÚʵÑé
|
|
¸÷λÖ÷ÈΡ¢ÀÏʦ£¬´ó¼ÒºÃ£º ±¾ÈËÊÇҩѧרҵѧÉú£¬¿ÎÌâ×é·¢ÏÖÁËÒ»¸öÐµĻ¯ºÏÎÓкÜÇ¿µÄÒÖÖÆÐÂÉúѪ¹ÜµÄ×÷Óã¬ÏëÓ¦ÓÃÔÚÖÎÁÆÑÛµ×£¨²¿£©ÐÂÉúѪ¹ÜÁìÓò£¬ÌØ´ËÀ´Ïò¸÷λÀÏʦÇë½Ì¹ØÓÚÑÛµ×£¨²¿£©ÐÂÉúѪ¹ÜÄ£Ðͼ°ÈçºÎÌåÍâ¡¢ÌåÄÚʵÑéµÄÎÊÌâ¡£ ¾¹ý²éÔÄ×ÊÁÏ£¬ÓÐһƪÂÛÎÄÓÐÈçϵĶÔÓÚл¯ºÏÎï¶ÔÑÛ²¿ÐÂÉúѪ¹ÜµÄÑо¿Ë¼Â·£º 1.Ex ovo chick chorioallantoic membrane assay 2.Silver nitrate cauterisation-induced corneal neovascularisation model 3.Argon-laser photocoagulation-induced choroidal neovascularisation assay 4.Oxygen-induced retinopathy neovascularisation assay 5.Protein expression analysis£¨Human umbilical vein endothelial cells£¬VEGF¡¢PEDF¡¢GAPDH£© ¸Ã˼·»ù±¾´ó²¿·Ö¶¼ÊÇÓö¯Îィ죬µ«ÊÇĿǰÎÒÃÇ·ÇÑÛ¿Æ×¨ÒµÑ§ÉúºÜÄѲÙ×÷£¬Çë½Ì¸÷λÀÏʦ£¬ÓÐûÓмòµ¥µÄ·½·¨£¬±ÈÈç°ëÌåÍâ¡¢Æ÷¹Ù»òÕßϸ°ûѧģÐÍ£¬¿ÉÒÔÑéÖ¤Ò©Îï¶ÔÑÛ²¿ÐÂÉúѪ¹ÜÉú³ÉµÄ×÷ÓÃÄØ£¿ лл¸÷λÀÏʦ£¬Çë¸÷λÀÏʦ²»Áߴͽ̣¡ |
» ²ÂÄãϲ»¶
ÃüÖÐÓë¹úÇàÎÞÔµ
ÒѾÓÐ97È˻ظ´
Çë½ÌÏ£¬Õâ¸ö±íÊöÊÇ·ñÉÏ»á
ÒѾÓÐ8È˻ظ´
Ô¤·ÀҽѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ218È˻ظ´
2024Äê¶Èɽ¶«Ê¡×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿Òѹ«Ê¾
ÒѾÓÐ141È˻ظ´
¿¼²©ÇóÖú£¬Ç󲩵¼ÍƼö
ÒѾÓÐ3È˻ظ´
»·¾³¾ú¿ÉÄÜÔì³ÉµÄGMP·çÏÕ£¬¹úÄÚÏÖÔÚ¹Ø×¢µÄÆóÒµ¶àÂð£¿
ÒѾÓÐ0È˻ظ´
΢ÉúÎï»·¾³¾ú¿ÉÄÜÔì³ÉµÄGMP·çÏÕ
ÒѾÓÐ0È˻ظ´
¹ã¶«Ò½¿Æ´óѧ100103²¡ÔÉúÎïѧÉÐÓе÷¼ÁÃû¶î£¬»¶ÓÌ | 4ÔÂ13ÈÕ15ʱ½ØÖ¹
ÒѾÓÐ0È˻ظ´
¹ã¶«Ê¡Ê¡ÊÐÁªºÏ»ù½ðÆÀÉó½áÊøÁËÂð£¿É¶Ê±ºò³ö½á¹û°¡
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ÌåÍâʵÑéÄ£Ðͽ¨Á¢Ï¸°ûÑ¡ÔñºÍÆÀ¼Û·½·¨
ÒѾÓÐ3È˻ظ´

jms_guan
ר¼Ò¹ËÎÊ (ÖøÃûдÊÖ)
- MedEPI: 7
- Ó¦Öú: 70 (³õÖÐÉú)
- ¹ó±ö: 0.017
- ½ð±Ò: 4734.7
- É¢½ð: 546
- ºì»¨: 14
- Ìû×Ó: 1101
- ÔÚÏß: 121.3Сʱ
- ³æºÅ: 845276
- ×¢²á: 2009-09-11
- ÐÔ±ð: GG
- רҵ: ÈËÀàÓªÑø
- ¹ÜϽ: ÉúÎïÒ½Ò©Çø

2Â¥2014-04-03 22:43:20














»Ø¸´´ËÂ¥